Related Experiment Videos

[Induced RAS association domain family gene 1A gene expression by arsenic trioxide in nasopharyngeal carcinoma cell]

Jun-Li Hu1, Yue-Fei Zhang, Zhi-Dong Qiu

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of GuangDong Medical College, Zhanjiang 524023, China.

Abstract

Insights

Arsenic trioxide (As2O3) was found to suppress nasopharyngeal carcinoma cell proliferation. As2O3 also activates the anti-oncogene RASSF1A, inhibiting cell cycle progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Nasopharyngeal carcinoma (NPC) is a significant health concern.
  • The anti-oncogene RAS association domain family gene 1A (RASSF1A) plays a crucial role in tumor suppression.
  • Understanding the regulation of RASSF1A is vital for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the effect of arsenic trioxide (As2O3) on the expression of the RASSF1A gene in the CNE-2Z nasopharyngeal carcinoma cell line.
  • To determine if As2O3 influences RASSF1A methylation status and gene expression at both mRNA and protein levels.

Main Methods:

  • CNE-2Z cells were treated with varying concentrations of As2O3.
  • Cell proliferation was assessed using trypan blue staining to determine IC50 values.
  • Cell cycle analysis was performed via flow cytometry.
  • RASSF1A gene methylation was analyzed using methylation-specific PCR.
  • RASSF1A mRNA and protein expression were quantified using reverse transcription PCR and Western blot, respectively.

Main Results:

  • As2O3 demonstrated a time- and dose-dependent suppression of CNE-2Z cell proliferation.
  • As2O3 treatment led to cell cycle arrest at the G2/M phase.
  • Increasing concentrations of As2O3 reduced RASSF1A gene methylation.
  • Concurrently, As2O3 treatment significantly upregulated RASSF1A expression at both mRNA and protein levels (P < 0.05).

Conclusions:

  • Arsenic trioxide effectively inhibits nasopharyngeal carcinoma cell proliferation.
  • As2O3 activates RASSF1A gene expression, likely through demethylation.
  • This activation of RASSF1A contributes to the inhibition of cell cycle progression in nasopharyngeal carcinoma cells.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: